The effect of pH and triethanolamine on sulfisoxazole complexation with hydroxypropyl-β-cyclodextrin

European Journal of Pharmaceutical Sciences

Volumn 20, Issue 3, 2003, Pages 285-293

  Gladys, Granero ^a   Claudia, Garnero ^a   Marcela, Longhi ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Hydroxypropyl cyclodextrin (HP CD); Inclusion complex; Multicomponent complex formation; Solubility; Sulfisoxazole; Thermal analysis

Indexed keywords

COMPLEXATION; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; PH EFFECTS; THERMOGRAVIMETRIC ANALYSIS;

MULTICOMPONENT SYSTEMS;

AMINES;

2 HYDROXYPROPYL BETA CYCLODEXTRIN; SULFAFURAZOLE; TRIETHANOLAMINE;

AQUEOUS SOLUTION; ARTICLE; COMPLEX FORMATION; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG EFFECT; DRUG FORMULATION; DRUG SOLUBILITY; DRUG SYNTHESIS; FREEZE DRYING; INFRARED SPECTROSCOPY; IONIZATION; PH; PRIORITY JOURNAL; RACEMIC MIXTURE; SOLID STATE; SOLUBILIZATION; THERMAL ANALYSIS; THERMOGRAVIMETRY;

EID: 0242270818     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(03)00202-1     Document Type: Article

References (23)

1. Casella R., Williams D.A., Jambhekar S.S. Solid-state β-cyclodextrin complexes containing indomethacin, ammonia and water. II. Solubility studies. Int. J. Pharm. 165:1998;15-22.
2. Corrigan O.I., Stanley C.T. Mechanism of drug dissolution rate enhancement from β-cyclodextrin-drug systems. J. Pharm. Pharmacol. 34:1982;621-626.
3. Elving P., Markowitz J., Rosenthal I. Preparation of buffer systems of constant ionic strength. Anal. Chem. 28:1956;1179-1180.
4. Esclusa-Díaz M.T., Gayo-Otero M., Pérez-Marcos M.B., Vila-Jato J.L., Torres-Labandeira J.J. Preparation and evaluation of ketoconazole-β-cyclodextrin multicomponent complexes. Int. J. Pharm. 142:1996;183-187.
5. 1H NMR and molecular modelling techniques for the investigation of the inclusion complex of econazole with α-cyclodextrin in the presence of malic acid J. Pharm. Biomed. Anal. 23:2000;25-31.
6. Fenyvesi, E., Vikmon, M., Szemán, J., Szejtli, J., Ventura, P., Pasini, M., 1994. Enhancement of the drug solubilizing capacity of hydroxypropyl-β-cyclodextrin by ternary complex formation. In: Proceedings of the 7th International Cyclodextrin Symposium, pp. 414-418.
7. Fenyves, E., Vikmon, M., Szejtli, J., Pasini, M., Ventura, P., 1996. Multicomponent complex formation with soluble cyclodextrin derivatives for the improvement of drug solubility. In: Proceedings of the European Symposium of Formulation of Poorly-Available Drugs For Oral Administration, pp. 286-289.
8. Ficarra R., Ficarra P., Di Bella M.R., Raneri D., Tommasini S., Calabró M.L., Villari A., Coppolino S. Study of the inclusion complex of atenolol with β-cyclodextrins. J. Pharm. Biomed. Anal. 23:2000;231-236.
9. Funk O., Schwabe L., Fromming K. Freeze-dried preparations of ketoprofen and heptakis-(2,6-dimethyl)-β-cyclodextrin. Drug Dev. Ind. Pharm. 20:1994;1957-1969.
10. Higuchi, T., Connors, K., 1965. Phase solubility techniques. In: Reilly, C. (Ed.), Advances in Analytical Chemistry and Instrumentation. Wiley/Interscience, New York, pp. 117-212.
11. Linares M., de Bertorello M.M., Longhi M. Solubilization of naphthoquinones by complexation with hydroxypropyl-β-cyclodextrin. Int. J. Pharm. 159:1997;13-18.
12. Loftsson T., Brewster M.E. Pharmaceutical applications of cyclodextrins. I. Drug solubilization and stabilization. J. Pharm. Sci. 85:1996;1017-1025.
13. Loftsson T., Olafsdóttir B., Fridriksdóttir H. Comparative study on inclusion complexation acetylsalicylic acid, cholecalciferol and melphalan with β- and γ-cyclodextrin and some their derivatives. Acta Pharm. Nord. 2:1990;303-312.
14. Loftsson T., Fridriksdóttir H., Thórisdóttir S., Stefánsson E., Siguroardóttir A.M., Guomundsson O., Sigthórsson T. 2-Hydroxypropyl-β-cyclodextrin in topical carbonic anhydrase inhibitor formulations. Eur. J. Pharm. Sci. 1:1994;175-180.
15. Loftsson T., Guomundsdóttir T.K., Fridriksdóttir H. The influence of water-soluble polymers and pH on hydroxypropyl-β-cyclodextrin complexation of drugs. Drug Dev. Ind. Pharm. 22:1996;401-405.
16. Moyano J.R., Gines J.M., Arias M.J., Rabasco A.M. Evaluation of dissolution characteristics of oxazepam-2-hydroxypropyl-β-cyclodextrin binary systems. Pharm. Acta Helv. 69:1994;81-90.
17. Mura P., Faucci M.T., Bettinetti G.P. The influence of PVP on naproxen complexation with HP-β-CD. Eur. J. Pharm. Sci. 13:2001;187-194.
18. Redenti E., Szente L., Szejtli J. Drug/cyclodextrin/hydroxy acid multicomponent systems: properties and pharmaceutical applications. J. Pharm. Sci. 89:2000;1-8.
19. Redenti E., Szente L., Szejtli J. Cyclodextrin complexes of salts of acidic drugs: thermodynamic properties, structural features, and pharmaceutical applications. J. Pharm. Sci. 90:2001;979-986.
20. Rudy, B.C., Senkowski, B.Z., 1993. Analytical Profiles of Drug Subtances, vol. 2. Academic Press, New York, pp. 487-506.
21. Steiner, T., Koellner, G., Gessler, K., Saenger, W., 1995. Isostructural replacement of an N-HO by a C-HO hydrogen bond in complex stabilization: crystal structures of β-cyclodextrin complexed with diethanolamine and with pentane-1,5-diol. J. Chem. Soc., Chem. Commun., 511-512.
22. Szejtli, J., 1991. Cyclodextrins in drug formulations. Part I. Pharm. Technol., 36-44.
23. Vikmon, M., Szemán, J., Szejtli, J., Pasini, M., Redenti, E., Ventura, P., 1994. Terfenadine/cyclodextrin/hydroxyacid multicomponent complexes. In: Proceedings of the 7th International Cyclodextrin Symposium, pp. 480-483.